LGND ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/6/2026
EPSå®çžŸïŒUSDïŒ2.42
売äžé«å®çžŸïŒUSDïŒ63.69M
Ligand Pharmaceuticals Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Ligand Pharmaceuticals Inc ã®æ±ºç®å ±åæžã次å Ligand Pharmaceuticals Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãLigand Pharmaceuticals Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Ligand Pharmaceuticals Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
LGND 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
LGND FY2025 決ç®
EPS (å幎åææ¯)6.132881.81%
売äžé« (å幎åææ¯)215.01M28.65%
Ligand Pharmaceuticals IncïŒLGNDïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 8/6/2026 | 06/2026 | 2.42/1.82 | 63.69M/60.76M | 32.50% | 4.82% |
| 5/7/2026 | 03/2026 | -0.67/1.82 | 51.72M/58.70M | -136.97% | -11.88% |
| 2/26/2026 | 12/2025 | 2.21/1.56 | 59.67M/55.59M | 41.33% | 7.33% |
| 11/6/2025 | 09/2025 | 5.99/1.93 | 115.46M/58.79M | 211.06% | 96.38% |
| 8/7/2025 | 06/2025 | 0.25/1.42 | 47.63M/43.87M | -82.36% | 8.56% |
| 5/8/2025 | 03/2025 | -2.21/1.21 | 45.33M/38.70M | -282.56% | 17.13% |
| 2/27/2025 | 12/2024 | -1.64/1.19 | 42.81M/39.02M | -237.66% | 9.71% |
| 11/7/2024 | 09/2024 | -0.39/1.35 | 51.81M/40.65M | -128.92% | 27.46% |